Exabis Library
Welcome to the e-CCO Library!
OP010: Azathioprine dose reduction in patients with inflammatory bowel disease on combination therapy: a prospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP010: Shallow whole-genome sequencing predicts the future cancer risk of low-grade dysplastic lesions arising in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP011: Comparison of adalimumab monotherapy and a combination with azathioprine for patients with Crohn’s disease: a prospective, multicentre, open-labelled clinical trial (DIAMOND study)
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP011: Etrolizumab treatment leads to early improvement in symptoms and inflammatory biomarkers in anti-TNF-refractory patients in the open-label induction cohort of the phase 3 HICKORY study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP011: Integration of whole-exome sequencing and RNA sequencing of intestinal biopsies in inflammatory bowel disease identifies inflammation-dependent effects
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP012: IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn’s disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP012: Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with ulcerative colitis undergoing (procto)colectomy with ileal pouch-anal anastomosis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP012: Risk factors for colorectal neoplasia in ulcerative colitis: results from the largest and longest-running colonoscopic surveillance programme
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP013: Disease management and outcomes of patients with Crohn's disease at high risk of recurrence. Results from PRACTICROHN study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP013: Evolution of corticosteroid use in Crohn’s disease patients between 1991 and 2014: results from the Dutch population-based Inflammatory Bowel Disease South Limburg cohort
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP014: A multicentre, double-blind, placebo-controlled phase 3 study of ustekinumab, a human interleukins-12/23p40 mab, in moderate-severe Crohn’s disease refractory to anti-tumour necrosis factor α: UNITI-1
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for inflammatory bowel disease and irritable bowel syndrome
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP014: Histological remission is predictive of improved clinical outcomes in patients with ulcerative colitis: results from the TOUCHSTONE open-label extension
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP015: Biomarker correlation with endoscopic outcomes in patients with Crohn’s disease: data from CALM
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP015: Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C TRIAL
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP015: Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn’s disease who are anti-tumour necrosis factor inadequate responders
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP016: Development and validation of diagnostic criteria for IBD-unclassified (IBDU) in children: a multicentre longitudinal study from the paediatric IBD Porto Group of ESPGHAN
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP016: Need for primary abdominal surgery, but not repeated surgery, has decreased: a nationwide study of temporal trends in Crohn surgery in Sweden 1990–2014
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM